Gold September: for a cure for childhood cancer
Gold September is the global awareness month for childhood cancer. Gold represents the value of children and reminds us of the importance of early diagnosis—which increases survival chances and allows for less aggressive treatments As pediatric oncologist Dr. Juliana Dal Ponte Bitencourt explains, “Early diagnosis enables the disease to be detected at initial stages, increasing […]
Lemonade for a cure: the sweetness of childhood in service of science
Small gestures can spark big transformations. For the third year in a row, the Lemonade for a Cure project has shown how children’s solidarity can power science. Kennedy, just 7 years old, set up her lemonade stand several times over the summer. With the support of her family and community, she didn’t just reach her […]
Two Nature group articles recognize MBI’s contribution to science
Researchers from the Cure Group Four Consortium, supported by MBI and focused on high-impact investigations into pediatric brain tumors, have recently published two articles in the Nature group. The articles feature the co-authorship of scientists from the Cure Group Four, whose research is backed by MBI and dedicated to groundbreaking studies on pediatric brain tumors. […]
Morning Joe
On August 7, MBI gained international recognition when it was featured on MSNBC — one of the leading news networks in the United States — during Morning Joe, a national broadcast. Our founder, Fernando Goldsztein, was invited to speak about the initiative’s global impact and advances in pediatric brain tumor research. He highlighted how the […]
MBI’s Voice in The Washington Post
On June 7, we had the honor of seeing a letter from our founder published in The Washington Post, one of the most respected newspapers in the United States. The letter, featured in the Letters to the Editor section, addresses the challenges faced by children with brain tumors, especially medulloblastoma, and calls out the lack […]
Lemonade for a Cure
This is the third season that 7-year-old Kennedy has dedicated her time to raising funds for pediatric cancer. With the support of her family and community, she has collected donations that, in 2025, are being directed to MBI. Kennedy’s mother, Kelly, shared that her daughter has many supporters and set up her lemonade stand several […]
MBI at the CAC2 2025 Annual Summit
In June, we participated for the first time in the CAC2 2025 Annual Summit, held at Children’s National Hospital in Washington, DC. MBI joined as a sponsor, and Fernando Goldsztein was one of the event’s speakers. Our founder led a packed session with leaders from other organizations dedicated to childhood cancer. He spoke about the […]
MBI Stands out at YPO Event with high-impact presentation
We recently participated in the YPO Impact Week in São Paulo, Brazil, with the panel “Turning Pain into Action: The Power of a Cause.” Our founder, Fernando Goldsztein, spoke about the future of research and shared how his personal experience with his son’s diagnosis led to the creation of MBI – now an international reference […]
MBI and its founder in the media spotlight
In the first months of 2025, MBI’s founder, Fernando Goldsztein, was featured in four outstanding Brazilian podcasts. Each conversation brought a unique perspective—some focused on leadership and the creation of an innovative operating model, while others highlighted family life or the scientific breakthroughs driving the Medulloblastoma Initiative forward. Every interview carried its own tone and […]
Clinical trial with innovative therapy begins treating children with cancer
In May 2025, the first children with medulloblastoma received the experimental treatment in the MATCHPOINT study, representing an unprecedented breakthrough funded by MBI. While these initial patients begin therapy, new pediatric and young adult participants with recurrent or refractory medulloblastoma continue to be recruited for the clinical trial in the U.S. FDA-approved in 2024, the […]